Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Mar;75(6):3038-42.
doi: 10.1128/JVI.75.6.3038-3042.2001.

Membrane-anchored peptide inhibits human immunodeficiency virus entry

Affiliations

Membrane-anchored peptide inhibits human immunodeficiency virus entry

M Hildinger et al. J Virol. 2001 Mar.

Abstract

Peptides derived from the heptad repeats of human immunodeficiency virus (HIV) gp41 envelope glycoprotein, such as T20, can efficiently inhibit HIV type 1 (HIV-1) entry. In this study, replication of HIV-1 was inhibited more than 100-fold in a T-helper cell line transduced with a retrovirus vector expressing membrane-anchored T20 on the cell surface. Inhibition was independent of coreceptor usage.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
(A) Maps of retroviral vectors. The SP and the MSD are derived from the LNGFR. The hinge is derived from the IgG heavy chain. (B) Amino acid sequence of the membrane-anchored T20 expressed by M87. (C) Amino acid sequence of the SP and the T20 region in the mutated proteins expressed from M87m1 through M87m3.
FIG. 2
FIG. 2
Expression of membrane-anchored T20. PM-1 cells were transduced with the retroviral vectors indicated and selected. The bulk cultures were stained either with a control human monoclonal antibody directed against gp120 (2G12) or with a human monoclonal antibody directed against a sequence within T20 (2F5) followed by a PE-conjugated anti-human IgG goat serum. Shaded curve, PM-1/MPIN; solid line, PM-1 transduced with the vector indicated.
FIG. 3
FIG. 3
Inhibition of HIV-1 replication by membrane-anchored T20. (A) PM-1 cells were transduced with different retroviral vectors encoding T20 and then selected with G418. These bulk cultures were infected with NL4–3 at a multiplicity of infection of 0.1. On day 5, medium was replaced and the concentration of p24 antigen was determined in supernatants collected on day 6. ∗, detection limit. (B) In parallel, the selected PM-1 cultures were infected with NL4–3AGFP and the spread of virus was monitored by flow cytometry. × M85; □ M86; ▴ M87; ○ MPIN. (C) Selected cultures were infected with NL4–3AGFP, and the spread of virus was monitored by flow cytometry. ▴ M87; ○ MPIN; □ M87m1; ▪ M87m2; □ M87m3. (D) Inhibition of a single round of infection by membrane-anchored T20. PM-1 transduced with the control vector MPIN or the vector M87 expressing the membrane-anchored T20 was infected with fivefold dilutions of a replication-deficient virus NL4–3envGFP pseudotyped either with VSV G protein or an HIV-1 envelope glycoprotein from one of the HIV strains depicted (solid bars). Cells were also transduced with an MLV vector with EGFP as a marker gene pseudotyed with the envelope glycoprotein of HIV-1 strain BH10 (shaded bar). Titers of different pseudotypes were determined on day 3 by flow cytometry for each of the PM-1 cultures. Titers on PM-1/M87 relative to the titer on PM-1/MPN are given.

References

    1. Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, Gruber G, Tauer C, Steindl F, Jungbauer A, et al. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retrovir. 1994;10:359–369. - PubMed
    1. Chan D C, Fass D, Berger J M, Kim P S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 1997;89:263–273. - PubMed
    1. Chun T-W, Engel D, Mizell S B, Hallahan C W, Fischette M, Park S, Davey R T, Dybul M, Kovacs J A, Metcalf J A, Mican J M, Berrey M M, Corey L, Lane H C, Fauci A S. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med. 1999;5:651–655. - PubMed
    1. Cosset F L, Takeuchi Y, Battini J L, Weiss R A, Collins M K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol. 1995;69:7430–7436. - PMC - PubMed
    1. Eckert D M, Malashkevich V N, Hong L H, Carr P A, Kim P S. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell. 1999;99:103–115. - PubMed

Publication types

MeSH terms

LinkOut - more resources